Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

Quantification of Symptom Relief Following Percutaneous Ablation of the Thyroid

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05501041

Enrollment

300

Registered

2022-08-15

Start date

2022-08-22

Completion date

2028-08-01

Last updated

2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid

Keywords

Thyroid Radiofrequency Ablation Procedure

Brief summary

The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).

Exclusion criteria

\- Decline to participate in research.

Design outcomes

Primary

Measure	Time frame	Description
Change in symptoms before and after ablation	Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment	Measured using a modified 6-item SYS questionnaire that objectively measures patient symptoms on a scale of 0=none, 1=moderate, 2=severe

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORThomas Atwell, MD

Mayo Clinic

Outcome results